The government on Wednesday apprised about the availability of medicinal drugs at reasonable prices in the country and said about 8,689 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been opened till February across the country, covering all districts of the country.
It has been a long journey for the Indian pharmaceutical industry from being merely an import dependent to emerging as a self‐reliant producer and now as one of the main export countries in the global market. Today the Indian pharmaceutical industry is the world’s third largest by volume and worth over $42 billion. Let's chart the future of this 'sunrise' sector as it stands presently
As Union Finance Minister Nirmala Sitharaman is scheduled to present Union Budget 2022 on February 1, the healthcare and diagnostics sector has pinned hope of an increase in the allocation in view of the pandemic that has been full of transitions. Health, at present, has become the biggest priority for people and nations alike. In India, the pandemic exposed several gaps in the existing healthcare infrastructure. However, the government has been quick to come up with reforms and policy levels
With the increasing relevance of the pharmaceutical industry, worldwide, as well as domestically, developments in regulation and policy pertaining to the industry are being keenly watched. We explore the expectations of a few opportunities and challenges that are projected for this industry in the coming year.